About Chindex International (NASDAQ:CHDX)
Chindex International Inc. is a healthcare company. The Company is engaged in providing health care services in China through the operations of United Family Healthcare and providing medical capital equipment and products through Chindex Medical Ltd. United Family Healthcare is a network of private primary care hospitals and affiliated ambulatory clinics. United Family Healthcare operates in Beijing, Shanghai, Tianjin and Guangzhou markets. Chindex Medical Ltd. is a joint venture company with manufacturing and distribution businesses serving both domestic China and export markets. Operations in Beijing Market include Beijing United Family Hospital main campus, United Family Rehabilitation Hospital and four affiliated satellite clinics. Operations in the Shanghai Market include Shanghai United Family Hospital main campus, two affiliated satellite clinics and two managed clinics. Operations in the Tianjin market include Tianjin United Family Hospital main campus.
Industry, Sector and Symbol
Industry Health Care Providers & Services
Sub-IndustryHealth Care Facilities
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Chindex International (NASDAQ:CHDX) Frequently Asked Questions
What is Chindex International's stock symbol?
Chindex International trades on the NASDAQ under the ticker symbol "CHDX."
How were Chindex International's earnings last quarter?
Chindex International Inc (NASDAQ:CHDX) issued its quarterly earnings data on Wednesday, March, 13th. The healthcare company reported $0.20 earnings per share for the quarter. The healthcare company had revenue of $43.51 million for the quarter, compared to analysts' expectations of $31.98 million. View Chindex International's Earnings History.
Who are some of Chindex International's key competitors?
Some companies that are related to Chindex International include UnitedHealth Group (UNH), Roche (ROG), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), Sanofi (SAN), Bayer (BAYN), CSL (CSL), Celgene (CELG), GlaxoSmithKline (GSK), Biogen (BIIB), AstraZeneca (AZN), Covidien (COV), Intuitive Surgical (ISRG), Beximco Pharmaceuticals (BXP), Regeneron Pharmaceuticals (REGN) and Edwards Lifesciences (EW).
How do I buy Chindex International stock?
Shares of Chindex International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Chindex International?
Chindex International's mailing address is 4340 E West Hwy Ste 1100, BETHESDA, MD 20814-4450, United States. The healthcare company can be reached via phone at +1-301-2157777.
MarketBeat Community Rating for Chindex International (CHDX)MarketBeat's community ratings are surveys of what our community members think about Chindex International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Chindex International (NASDAQ:CHDX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Chindex International (NASDAQ:CHDX) Earnings History and Estimates Chart
Chindex International (NASDAQ CHDX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/11/2014||Q214||($0.04)||$46.00 million||$55.50 million||View||N/A|
|5/8/2014||Q1 2014||($0.08)||$49.89 million||View||N/A|
|3/17/2014||Q4||($0.12)||$43.50 million||$48.80 million||View||Listen|
|11/11/2013||Q3 2013||($0.23)||$43.06 million||View||N/A|
|8/7/2013||Q2 2013||($0.01)||$45.98 million||View||N/A|
|3/13/2013||Q4 2012||$0.20||$31.98 million||$43.51 million||View||N/A|
Chindex International (NASDAQ:CHDX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Chindex International (NASDAQ:CHDX)
No dividend announcements for this company have been tracked by MarketBeat.com
Chindex International (NASDAQ CHDX) Insider Trading and Institutional Ownership History
Chindex International (NASDAQ CHDX) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/22/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||18||$7.22||$129.96|| |
|12/19/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||100||$7.50||$750.00|| |
|12/16/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||27||$6.42||$173.34|| |
|12/11/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||241||$16.16||$3,894.56|| |
|12/8/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||40||$6.64||$265.60|| |
|12/7/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||624||$10.52||$6,564.48|| |
|12/4/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||100||$5.67||$567.00|| |
|12/3/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||100||$5.37||$537.00|| |
|10/5/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||16||$10.52||$168.32|| |
|9/30/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||2,543,472||$24.00||$61,043,328.00|| |
|9/29/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||1,696||$8.80||$14,924.80|| |
|9/12/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||15,000||$10.43||$156,450.00|| |
|7/19/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||339||$11.50||$3,898.50|| |
|7/18/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||6,308||$23.49||$148,174.92|| |
|7/17/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||3,120||$12.94||$40,372.80|| |
|6/16/2014||Julius Oestreicher||Director||Sell||5,053||$23.68||$119,655.04|| |
|5/15/2014||Julius Oestreicher||Director||Sell||22,500||$23.58||$530,550.00|| |
|4/30/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||22||$12.64||$278.08|| |
|3/19/2014||Elyse Beth Silverberg||EVP||Sell||16,400||$19.20||$314,880.00|| |
Chindex International (NASDAQ CHDX) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Chindex International (NASDAQ:CHDX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Chindex International (NASDAQ:CHDX) Income Statement, Balance Sheet and Cash Flow Statement
Chindex International (NASDAQ CHDX) Stock Chart for Sunday, February, 25, 2018